Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma

Publisher： Karger

E-ISSN： 1421-9778|42|1|373-382

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.42, Iss.1, 2017-05, pp. : 373-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating Tumor Cells in the Adenocarcinoma of the Esophagus

By Gallerani Giulia   Fabbri Francesco  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-08 ,pp. : 1266-1266

MDPI

Access to resources Recommend Favorite

Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma

By Li Na   Li Yang   Li Zengxun   Huang Chongbiao   Yang Yanhui   Lang Mingxiao   Cao Junli   Jiang Wenna   Xu Yu   Dong Jie   Ren He  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 799-799

MDPI

Access to resources Recommend Favorite

Avarol Induces Apoptosis in Pancreatic Ductal Adenocarcinoma Cells by Activating PERK–eIF2α–CHOP Signaling

By Namba Takushi   Kodama Rika  

Marine Drugs, Vol. 13, Iss. 4, 2015-04 ,pp. : 2376-2389

MDPI

Access to resources Recommend Favorite

MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt

By  

Cellular Physiology and Biochemistry, Vol. 38, Iss. 6, 2016-05 ,pp. : 2366-2374

Karger

Access to resources Recommend Favorite

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

By Adamska Aleksandra   Domenichini Alice   Falasca Marco  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1338-1338

MDPI

Access to resources Recommend Favorite